Kailera Therapeutics Inc (KLRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -148,955 | N/A |
| Depreciation Amortization | 310 | N/A |
| Accounts payable and accrued liabilities | 4,690 | N/A |
| Other Working Capital | 16,781 | N/A |
| Other Operating Activity | 6,964 | 0 |
| Operating Cash Flow | $-120,210 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -2,088 | N/A |
| Purchase Of Investment | -490,511 | N/A |
| Investing Cash Flow | $-492,599 | $N/A |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 100,000 | N/A |
| Common Stock Issued | 100 | N/A |
| Other Financing Activity | 498,559 | 0 |
| Financing Cash Flow | $598,659 | $N/A |
| Beginning Cash Position | 175,178 | N/A |
| End Cash Position | 161,028 | N/A |
| Net Cash Flow | $-14,150 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -120,210 | N/A |
| Capital Expenditure | -2,088 | N/A |
| Free Cash Flow | -122,298 | 0 |